-+ 0.00%
-+ 0.00%
-+ 0.00%

OBSIDIAN THERAPEUTICS - 33% OF PATIENTS AT RP2D IN DEEP ONGOING RESPONSE AT 12 MONTHS POST-INFUSION

Reuters·11/06/2026 14:09:23

Please log in to view news